.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
McKinsey
Deloitte
US Army
Moodys
Farmers Insurance
Teva
Fish and Richardson
Baxter
Argus Health

Generated: June 22, 2017

DrugPatentWatch Database Preview

Claims for Patent: 5,114,976

« Back to Dashboard

Claims for Patent: 5,114,976

Title: Method for treating certain psychiatric disorders and certain psychiatric symptoms
Abstract:There is disclosed a method for treating psychiatric disorders including circadian rhythm disorders, borderline personality disorders, personality disorders, Late Luteal Phase Dysphoric Disorder, psychoactive substance use disorders, sexual disorders, and schizophrenia and certain psychiatric symptoms including stress, anger, worry, rejection sensitivity and lack of mental or physical energy with administration of a nontoxic dose of a serotonin re-uptake blocker. Preferably, the serotonin re-uptake blocker is fluoxetine or norfluoxetine.
Inventor(s): Norden; Michael J. (Seattle, WA)
Assignee:
Application Number:07/610,339
Patent Claims: 1. A method for enhancing the treatment of a disorder selected from the group consisting of circadian rhythm disorder, borderline personality disorder, hypochondriasis, late luteal phase dysphoric disorder, psychoactive substance use disorder, sexual disorder and schizophrenia comprising, administering a therapeutically effective, nontoxic dose of fluoxetine, and derivatives and pharmaceutically acceptable salts thereof.

2. The method of claim 1 wherein the serotonin re-uptake blocker is fluoxetine or norfluoxetine.

3. The method of claim 2 wherein the daily adult dose of fluoxetine or norfluoxetine is from about 2 mg to about 80 mg.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
US Army
UBS
Fuji
Mallinckrodt
Cipla
Express Scripts
Chubb
AstraZeneca
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot